Crossmark

Efficacy and Safety of Ertugliflozin in Patients With Diabetes Mellitus Inadequately Controlled by Sulfonylurea Monotherapy: a Substudy of VERTIS CV

Published Online: 2021-03-10

Published Print: 2021-04

Authors

Strojek, Krzysztof

Pandey, A. Shekhar

Dell, Vanessa

Sisson, Melanie

Wang, Shuai

Huyck, Susan

Liu, Jie

Gantz, Ira
Funding

Funding for this research was provided by:

Merck Sharp and Dohme

Pfizer
License Information

Text and Data Mining valid from 2021-03-10

Version of Record valid from 2021-03-10
More Information

Article History

Received: 17 December 2020

Accepted: 30 January 2021

First Online: 10 March 2021

Document is current